YONGHE MED.GR.DL-0000025 Market Cap ($109.02 Million)
Market Cap & Net Worth: YONGHE MED.GR.DL-0000025 (L97)
YONGHE MED.GR.DL-0000025 market cap. YONGHE MED.GR.DL-0000025 (F:L97) has a market capitalization of $109.02 Million (€93.25 Million) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #18671 globally and #1728 in its home market, demonstrating a -1.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying YONGHE MED.GR.DL-0000025's stock price €0.22 by its total outstanding shares 500111416 (500.11 Million). Also see how efficiently does YONGHE MED.GR.DL-0000025 generate cash for how efficiently the company converts equity into cash flow.
YONGHE MED.GR.DL-0000025 Market Cap History (2021–2026)
YONGHE MED.GR.DL-0000025 market cap history from 2021 to 2026. Data shows change from $945.61 Million to $130.97 Million (-34.77% CAGR). Check YONGHE MED.GR.DL-0000025 stock price for real-time trading data and today's change.
YONGHE MED.GR.DL-0000025 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how YONGHE MED.GR.DL-0000025's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore YONGHE MED.GR.DL-0000025 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.05x
YONGHE MED.GR.DL-0000025's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.35x
YONGHE MED.GR.DL-0000025's market cap is 1.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $945.61 Million | $2.17 Billion | $120.19 Million | 0.44x | 7.87x |
| 2022 | $795.17 Million | $1.41 Billion | -$85.86 Million | 0.56x | N/A |
| 2023 | $134.48 Million | $1.78 Billion | -$546.39 Million | 0.08x | N/A |
| 2024 | $59.64 Million | $1.80 Billion | -$226.34 Million | 0.03x | N/A |
| 2025 | $99.40 Million | $1.81 Billion | $73.71 Million | 0.05x | 1.35x |
Competitor Companies of L97 by Market Capitalization
Companies near YONGHE MED.GR.DL-0000025 in the global market cap rankings as of November 1, 2026. Also see YONGHE MED.GR.DL-0000025 (L97) total assets for a full breakdown of the balance sheet.
Key companies related to YONGHE MED.GR.DL-0000025 by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of YONGHE MED.GR.DL-0000025 (2021–2026)
Market capitalization of YONGHE MED.GR.DL-0000025 from 2021 to today. Between 2021 and today, YONGHE MED.GR.DL-0000025's market cap moved from $945.61 Million to $ 130.97 Million, with a yearly change of -34.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €130.97 Million | +31.76% |
| 2025 | €99.40 Million | +66.67% |
| 2024 | €59.64 Million | -55.65% |
| 2023 | €134.48 Million | -83.09% |
| 2022 | €795.17 Million | -15.91% |
| 2021 | €945.61 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of YONGHE MED.GR.DL-0000025 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $109.02 Million USD |
| MoneyControl | $109.02 Million USD |
| MarketWatch | $109.02 Million USD |
| marketcap.company | $109.02 Million USD |
| Reuters | $109.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About YONGHE MED.GR.DL-0000025
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; investment and management; and wig business. The company was founded in 2005 and is headquartered in Beijing, China.